1. US Food and Drug Administration. Artificial Intelligence and Machine Learning in Software as a Medical Device (accessed 18 September 2019).
https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device
2. Chalmers, I., Glasziou, P., Heneghan, C., Shepperd, S., Loudon, K. & Bossuyt, P. M. Avoidable waste in the production and reporting of research evidence. Lancet 374, 86–89 (2009).
3. Schulz, K. F., Altman, D. G. & Moher, D., for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int. J. Surg. 9, 672–677 (2011).
4. Chan, A. W., Tetzlaff, J. M., Altman, D. G., Dickersin, K. & Moher, D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet 381, 91–92 (2013).
5. EQUATOR Network. Reporting guidelines under development (EQUATOR Network, accessed 4 August 2019);
http://www.equator-network.org/library/reporting-guidelines-under-development/